genotype and phenotype in previous studies, except for one recent study by Vincent et al., where mild ERG abnormalities were reported to be more commonly associated with missense changes [19] .
In the present study, we performed mutation screening of the RS1 gene in a cohort of affected individuals with XLRS. Fifteen intragenic mutations and a large deletion were identified in this cohort of patients. Nine of these mutations are novel. No correlation between genotype and phenotype was revealed in this study.
METHODS
Clinical studies: This study was approved by the Beijing Tongren Hospital Joint Committee on Clinical Investigation and was performed in accordance with the tenets of the Declaration of Helsinki. Sixteen families with XLRS were recruited for this study. After informed consent was obtained, each proband underwent clinical examinations, including best-corrected visual acuity (BCVA) using E decimal charts, slit-lamp biomicroscopy, fundus examination and photography, single-flash ERG, and OCT. The diagnostic criteria in XLRS individuals included a history of bilateral visual impairment at or before school age, radiating cystic-like changes in the macular region, blunted foveal reflex with or without peripheral lesions, and a decreased ERG b-wave.
Detection of mutations in the RS1 gene: Peripheral blood samples were collected from all the participants by venipuncture in heparinized collecting tubes and stored at 4 °C for less than 1 week. Genomic DNA was extracted from peripheral blood leukocytes using a genomic DNA extraction Abbreviations: M, male; OD, right eye; OS, left eye; EC, early childhood; OU, both eyes; RD, retinal detachment; VH, vitreous hemorrhage, NA, data not available; MA, macular atrophy; *, large retinoschisis cavity.
and purification kit (Vigorous Whole Blood Genomic DNA Extraction Kit, Vigorous Beijing, China), according to the manufacturer's protocol. In briefly, whole erythrocytes were lysed with the lysis buffer and white cells pellets were extracted, then DNA was extracted from the pellets using lysis buffer, washing buffer, and solving buffer. The coding regions and the exon-intron boundaries of the RS1 gene were amplified by PCR in the patients from the 16 families using the primers described in Table 1 . PCR assays were performed using standard reaction mixtures and purified PCR products were directly sequenced on an ABI Prism 373A DNA sequencer (Applied Biosystems, Foster City, CA). Nucleotide sequences were compared with the published cDNA sequence of RS1 (GenBank NM_000330.3). For the RS1 gene, cDNA numbering +1 corresponds to A in the ATG translation initiation codon in RS1.
Allele-specific polymerase chain reaction analysis: Allelespecific PCR analysis was performed in the available family members and in 100 normal controls to confirm the variations found in the sequencing. Allele-specific reverse primers in exon5 and exon6 of the RS1 gene are described in Table 1 . The PolyPhen (Polymorphism Phenotyping) program was used to predict the potential functional impact of an amino acid change [20] .
RESULTS
Clinical findings: Twenty-two male individuals from the 16 families were diagnosed with retinoschisis by clinical examination and family history review (Figure 1 ). Of the 22 affected individuals, 16 probands were evaluated; their clinical features are summarized in Table 2 . Eleven of the 16 (11/16) probands had been diagnosed in their first decade and the median age at diagnosis was 13.1 years (range 4-41 years). The BCVA at the time of diagnosis ranged from 1.0 to hand movement. Retinal findings varied considerably. Twelve patients (22 eyes) presented a typical cystic-like foveal schisis, while three patients (5 eyes) also had peripheral retinal schisis (Figure 2A-D) . Patients 113050 and 113100 had only peripheral retinal schisis ( Figure 2E ). Patient 113100 had 1.0 visual acuity and his OCT images revealed peripheral schisis cavities but failed to show any evidence of foveal cystic changes ( Figure 2F ). His left eye had visual acuity only for hand movement due to a recent spontaneous vitreous hemorrhage. Foveal atrophy was revealed in one elder proband (>40 year old) through his fundus photography and OCT findings (Figure 2 G,H) . In addition to the typical clinical features of XLRS, this cohort of patients also exhibited retinal detachment, vitreous hemorrhage, strabismus, and cataract.
The clinical features of patient 113160 are worthy of further description. The 27-year-old man had bilateral poor vision and nystagmus in his early childhood. Because of his local clinic's constraints, he was initially diagnosed with optic atrophy and sent to our laboratory for the related molecular analysis. His fundus examination showed temporal pallor of the optic discs, a large elevated mound in the posterior pole with a size of over 5 disk diameters, and pigmentary changes in the peripheral retina (Figure 3 ). His OCT scanning revealed two unusually large retinoschisis cavities in both eyes, which corresponded to the large elevated area observed in his fundus (Figure 3 ). His ERG testing showed a "negative" ERG response with the b-wave amplitude severely decreased and the a-wave mildly decreased.
Mutation analysis: Sequencing the RS1 gene identified 16 mutations in this cohort of Chinese families with XLRS. Each mutation was found only once and nine were detected for the first time in this study ( Table 2 ). All patients carried hemizygous mutations, while their mothers harbored the heterozygous mutations (Figure 1 Ile125fs+1X) , and c.489del G (p. W163fsX); and one large deletion that included the entire exon 1. Allele-specific PCR analyses showed that the novel mutations cosegregated with the phenotype in the cohort patients, and none of the mutations were detected in 100 normal controls. The PolyPhen program analysis predicted that four of the novel missense mutations (p.Y151H, p.Y166H, p.K167E, and p.I194N) were probably damaging. The large genomic deletion was detected by the failure of amplification of exon 1 for proband 113040. This deletion is at least 9,174 bp (from 955 bp upstream of the exon1 splice acceptance site to 8,132 bp downstream of the exon splice donor site); however, we were unable to perform an exact size estimation or breakpoint characterization of the large deletion due to the inability to amplify across this region in both the patient and the healthy individuals.
DISCUSSION
In this study, we screened RS1 mutations from 16 patients belonging to 16 Chinese families and evaluated the genotype and phenotype correlation between these patients. Sixteen different mutations were identified, nine of which have not been previously reported. No obvious genotype-phenotype association was observed in this small cohort of Chinese patients.
The majority of the RS1 mutations detected in this study were missense mutations (8/16), although nonsense mutations (2/16), a splicing site mutation (1/16), small insertion or deletion (4/16), and a large deletion (1/16) were all detected. In agreement with previously published XLRS studies, the mutations found in this study were not distributed randomly over the gene. Eight missense mutations were located in exons 4-6; these encode the discoidin domain, which extends from residue 63 to residue 219. The remaining seven mutations, which resulted in premature translation termination, were scattered in exon 5, etc which encode the leader sequence (residues 1-23) and the RS1 domain (residues 24-62). Only one mutation was identified in exon4 in this study (exon4: 6.3%; exon5: 43.8%; exon6: 25.0%), in contrast to the data from the Retinoschisis Database ([dmd]; exon 4: 42.7%; exon 5: 16.3%; exon 6: 26.9). This may reflect the relatively small number of patients in our study.
The four novel missense mutations were all located in the discoidin domain and residues (Y151, Y166, K167, and I194), which are highly conserved among different species ( Figure  4B ). These novel mutations may result in protein misfolding and intracellular retention by the endoplasmic reticulum (ER) quality control system. One large genomic deletion around exon1 was detected in family RSF5. This deletion is more than 9,174 bp and should include the promoter region of the RS1 gene; therefore, the deletion may lead to a nonfunctioning null allele or total absence of retinoschisin. At present, about 20 large genomic deletions have been reported and most of these involve exon1 [8, [21] [22] [23] [24] .
The spectrum of RS1 mutations found in this study is relatively broad, as each patient from the different families carried his own individual mutation. No significant genotype and phenotype correlation could be observed in this study. The 16 Chinese XLRS families recruited in this study showed considerable heterogeneity in the clinical severity of the disease, with BCVA ranging from hand movement to 1.0 (20/20) , and a wide variation was observed between both eyes in each patient. One limitation of this study is that only one patient from each family was clinically evaluated; thus, there is no way to compare the clinical features of patients with the same mutations. Patient 113040 that harbored the exon1 deletion showed a mild clinical phenotype, with a BCVA of 0.4. Fundal examination revealed bilateral spoke-wheellike retinoschisis involving the maculae. In contrast to this patient, a patient with an exon1 deletion reported by Chan et al. presented clinical features of greater severity, including both foveal and peripheral retinoschisis associated with inferior retinal detachment [22] .
In conclusion, we have broadened the mutation spectrum for XLRS by identifying 16 mutations of the RS1 gene. This type of molecular analysis can provide a molecular diagnosis, especially for atypical cases such as in the very young or elderly XLRS patients. Molecular genetic analysis is very important when it comes to identifying carriers, who usually do not have any symptoms; timely genetic counseling may be helpful in family planning decisions.
